A/APublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Progression free survival in metastatic colorectal cancer (chemotherapy interaction) compared to the general population.
A/GPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Progression free survival in metastatic colorectal cancer (chemotherapy interaction).
G/GPublished research associates this genotype with typical/baseline likelihood of Progression free survival in metastatic colorectal cancer (chemotherapy interaction) — no copies of the reported risk allele.
rs885036 is a single position in the genome, in or near the GnT-IVa gene. Published research associates it with progression free survival in metastatic colorectal cancer (chemotherapy interaction). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
What conditions is rs885036 linked to?
On MyGeneLog this position is linked to Colorectal Cancer. The research behind each link, and its sources, are set out on that condition page.
Does having rs885036 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs885036 come from?
GWAS Catalog, PLoS One 2015, PMID:26222057. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.